Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN
May 14, 2021
Vaccine chief blames Japan's slow inoculation drive on drug approval system
Japan's COVID-19 vaccine chief has blamed a rigid drug approval system for a slow inoculation campaign that is relying on only one approved shot, as a fourth wave of infections raises worries amid preparations for the Summer Olympics.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2021
Chinese shot takes controversial path to vaccinating the world
Used to operating within China, where public opinion is censored, Chinese vaccine-makers have had a tough time showing their 'growth in front of the world,' an expert said.
Japan Times
JAPAN / FOCUS
May 12, 2021
How domestic clinical trials slow Japan's vaccine approval process
To achieve greater efficiency and flexibility, some have argued that Japan should institute its own version of the emergency use authorization framework seen in the U.S.
Japan Times
ASIA PACIFIC
May 12, 2021
China’s Sinovac shot found highly effective in real world study
Indonesian data adds to signs out of Brazil that the shot is more effective than it proved in the testing phase, which was beset by divergent efficacy rates and questions over transparency.
Japan Times
WORLD
May 11, 2021
Pfizer-BioNTech COVID-19 shot cleared for adolescents in U.S.
The move comes ahead of the summer camp season and before the start of the new school year in September.
Japan Times
ASIA PACIFIC
May 8, 2021
WHO approves Sinopharm vaccine in potential boost to COVAX pipeline
The vaccine, one of two main Chinese coronavirus vaccines, is the first developed by a non-Western country to win WHO backing.
Japan Times
EDITORIALS
May 8, 2021
World shares India’s pain with growing COVID-19 crisis
The WHO estimates that 25% of global deaths last week occurred in India, a death toll that exceeded 3,700 lives per day.
Japan Times
ASIA PACIFIC
May 7, 2021
The world turns to China for vaccines after India and U.S. stumble
Some experts are worried about the potential impact of widely deploying Chinese shots that have demonstrated lower efficacy rates than those made by Pfizer and Moderna.
Japan Times
WORLD
May 7, 2021
Biden's vaccine-patent gambit turns up the heat on drugmakers
By supporting the World Trade Organization process, the U.S. president can satisfy progressives while engaging in talks on a waiver that may never reach consensus.
Japan Times
WORLD
May 6, 2021
In a reversal, U.S. backs giving poorer countries access to COVID-19 vaccine patents and tech
'This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,' Biden's top trade negotiator said in a statement
Japan Times
WORLD
May 4, 2021
White House backs Pfizer’s move to begin vaccine exports
Early U.S. production wasn't subject to an export ban but was gobbled up entirely by the government, which used wartime powers to prioritize its orders.
Japan Times
WORLD / Science & Health
May 1, 2021
Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds
A single dose of the vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19.
Japan Times
JAPAN
May 1, 2021
Japan to approve Moderna vaccine as soon as May 21, report says
The Moderna vaccine would be the second to get approved in Japan and will be used in the nation's large inoculation centers that will open in Tokyo and Osaka from May 24, the report said.
Japan Times
WORLD / Science & Health
Apr 30, 2021
COVID-19 shots come in bulk, but the world needs single servings
Vials full of doses often must be kept in extreme cold, and once opened have to be used quickly, making delivery to smaller, far-flung populations difficult.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?